Ameriprise Financial Inc Pulmonx Corp Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $221,270 - $441,749	-15,805 Reduced 24.92%	47,625 $701,000
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $2,218 - $3,743	105 Added 0.17%	63,430 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $490,380 - $744,150	16,500 Added 35.24%	63,325 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $93,547 - $115,647	-2,600 Reduced 5.26%	46,825 $1.69 Million
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $84,040 - $129,001	1,910 Added 4.02%	49,425 $2.26 Million

Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $1.87 Million - $3.28 Million	47,515 New	47,515 $3.28 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.